Your session is about to expire
← Back to Search
Procedure
Airway Management for Critically Ill Children (Pedi-PART Trial)
N/A
Recruiting
Led By Henry E Wang, MD, MS
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Requiring active airway management (BVM or higher level of respiratory support)
Experiencing cardiopulmonary arrest, major trauma, or respiratory failure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing different ways to help critically ill children breathe better before they reach the hospital. They are comparing three methods: using a bag valve mask only, using a bag valve mask followed by a
Who is the study for?
This trial is for children under 18 who've had a cardiac arrest, major trauma, or respiratory failure and need emergency airway management. They must be at least 24 hours old and receive care from Pedi-PART EMS as part of an emergency response.
What is being tested?
The study compares prehospital airway management strategies in critically ill children: BVM-only, BVM followed by SGA (supraglottic airway), and BVM followed by ETI (endotracheal intubation). It's to see which method helps more kids stay out of the ICU after 30 days.
What are the potential side effects?
Possible side effects include complications related to incorrect tube placement, aspiration pneumonia due to vomiting with compromised airways, injury to teeth or soft tissues during intubation, and hyperventilation or hypoventilation from improper use of BVM.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I need help with breathing, such as a bag valve mask or more advanced support.
Select...
I am currently experiencing a severe heart or lung emergency.
Select...
I am younger than 18 years old.
Select...
I received emergency life-saving care from Pedi-PART EMS.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
30-day ICU-free survival
Secondary study objectives
Neurologic outcome upon hospital discharge
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Active Control
Group I: BVM followed by SGA [BVM+SGA]Active Control2 Interventions
Initial strategy of airway management using Bag-Valve-Mask (BVM) followed by Supraglottic Airway (SGA).
Group II: BVM-onlyActive Control1 Intervention
Initial strategy of airway management using Bag-Valve-Mask (BVM) only.
Group III: BVM followed by ETI [BVM+ETI]Active Control2 Interventions
Initial strategy of airway management using Bag-Valve-Mask (BVM) followed by Endotracheal Intubation (ETI).
Find a Location
Who is running the clinical trial?
University of UtahOTHER
1,147 Previous Clinical Trials
1,696,621 Total Patients Enrolled
14 Trials studying Wounds and Injuries
5,765 Patients Enrolled for Wounds and Injuries
Ohio State UniversityLead Sponsor
871 Previous Clinical Trials
652,972 Total Patients Enrolled
18 Trials studying Wounds and Injuries
12,432 Patients Enrolled for Wounds and Injuries
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,943 Previous Clinical Trials
47,794,933 Total Patients Enrolled
32 Trials studying Wounds and Injuries
14,916 Patients Enrolled for Wounds and Injuries
Henry E Wang, MD, MSPrincipal InvestigatorOhio State University